Market Tracker

01/20 5:16pm ET

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.21
Delayed Data
As of Jan 20
 -0.01 / -0.82%
Today’s Change
0.69
Today|||52-Week Range
1.76
+5.22%
Year-to-Date
No recent news for CASI Pharmaceuticals Inc.

Today’s Trading

Previous close1.22
Today’s open1.21
Day’s range1.18 - 1.23
Volume19,586
Average volume (3 months)62,327
Market cap$72.8M
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)+76.09%
Earnings growth (this year)-2.27%
Earnings growth (next 5 years)--
Revenue growth (last year)+101.09%
P/E ratioNM
Price/Sales652.83
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.00-0.79%
CEMIChembio Diagnostics ...-0.05-0.80%
IPCIIntellipharmaceutics...-0.06-2.31%
LIFEaTyr Pharma Inc0.000.00%
Data as of 4:00pm ET, 01/20/2017

Financials

Next reporting dateMarch 24, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$47.7K
Annual profit (last year)-$7.2M
Net profit margin-15,104.01%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ken Keyong Ren
COO, Secretary, Vice President &
General Counsel
Cynthia Wong Hu
Corporate headquarters
Rockville, Maryland

Forecasts